Author:
Bonderman Diana,Pölzl Gerhard,Ablasser Klemens,Agis Hermine,Aschauer Stefan,Auer-Grumbach Michaela,Binder Christina,Dörler Jakob,Duca Franz,Ebner Christian,Hacker Marcus,Kain Renate,Kammerlander Andreas,Koschutnik Matthias,Kroiss Alexander Stephan,Mayr Agnes,Nitsche Christian,Rainer Peter P.,Reiter-Malmqvist Susanne,Schneider Matthias,Schwarz Roland,Verheyen Nicolas,Weber Thomas,Zaruba Marc Michael,Badr Eslam Roza,Hülsmann Martin,Mascherbauer Julia
Abstract
SummaryThe prevalence and significance of cardiac amyloidosis have been considerably underestimated in the past; however, the number of patients diagnosed with cardiac amyloidosis has increased significantly recently due to growing awareness of the disease, improved diagnostic capabilities and demographic trends. Specific therapies that improve patient prognosis have become available for certain types of cardiac amyloidosis. Thus, the earliest possible referral of patients with suspicion of cardiac amyloidosis to an experienced center is crucial to ensure rapid diagnosis, early initiation of treatment, and structured patient care. This requires intensive collaboration across several disciplines, and between resident physicians and specialized centers. The aim of this consensus statement is to provide guidance for the rapid and efficient diagnosis and treatment of light-chain amyloidosis and transthyretin amyloidosis, which are the most common forms of cardiac amyloidosis.
Funder
Medical Writer Fund
Medical University of Vienna
Publisher
Springer Science and Business Media LLC
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献